Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment … now!
- 1 July 1995
- journal article
- editorial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 32 (5) , 1531-1534
- https://doi.org/10.1016/0360-3016(95)00262-w
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Time course and incidence of late complications in patients treated with radiation therapy for FIGO Stage IB carcinoma of the uterine cervixInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Early and late radiotherapeutic morbidity in 442 consecutive patients with locally advanced carcinoma of the uterine cervixInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Radiobiological considerations in the design of clinical trialsRadiotherapy and Oncology, 1994
- Analysis of the probability and risk of cause-specific failureInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1994
- The recording of morbidity related to radiotherapyRadiotherapy and Oncology, 1989
- Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical studyRadiotherapy and Oncology, 1989
- Myelopathy following radiotherapy of bronchial carcinoma with large single fractions: A retrospective studyInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- Survival Curve for Cancer Patients Following TreatmentJournal of the American Statistical Association, 1952